X-15321558-T-C
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_002641.4(PIGA):āc.1403A>Gā(p.Tyr468Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000015 in 1,203,943 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_002641.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PIGA | NM_002641.4 | c.1403A>G | p.Tyr468Cys | missense_variant | 6/6 | ENST00000333590.6 | NP_002632.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PIGA | ENST00000333590.6 | c.1403A>G | p.Tyr468Cys | missense_variant | 6/6 | 1 | NM_002641.4 | ENSP00000369820.3 |
Frequencies
GnomAD3 genomes AF: 0.00000889 AC: 1AN: 112492Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34624
GnomAD3 exomes AF: 0.000104 AC: 19AN: 183452Hom.: 0 AF XY: 0.0000736 AC XY: 5AN XY: 67902
GnomAD4 exome AF: 0.0000156 AC: 17AN: 1091398Hom.: 0 Cov.: 28 AF XY: 0.0000112 AC XY: 4AN XY: 356898
GnomAD4 genome AF: 0.00000889 AC: 1AN: 112545Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34687
ClinVar
Submissions by phenotype
Multiple congenital anomalies-hypotonia-seizures syndrome 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 04, 2022 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 19, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at